Susheela Tridandapani, PhD
Davis Heart and Lung Research Institute
473 W 12th Ave / Room 405-D
Columbus, OH 43210
Phone: (614) 247-6768
Email: Susheela.Tridandapani@osumc.edu
Current OSU Appointment
Professor, Pulm,Allergy,Crit Care & Sleep
Biographical Narrative
Dr. Susheela Tridandapani is a Professor of Internal Medicine and Co-Director of Research in the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine. She obtained her PhD in 1998, following which she pursued postdoctoral work at Harvard University and at the Ohio State University. She was appointed to the Faculty in Internal Medicine in 2002. Dr. Tridandapani has a fully funded (NIAID, NCI) research program examining the molecular mechanisms of innate immune responses to bacterial pathogens and IgG-immune complexes, particularly in the context of monoclonal antibody therapy for cancer. She has trained and continues to train numerous graduate students and postdoctoral fellows who have successfully competed for prestigious fellowships from NIH, AHA and ACS. She currently serves as the Co-Director of the Lung Inflammation T32 Program.
Chapters In Books
Tridandapani S, CL Anderson. 2005. Regulation of FcyR-Mediated Phagocytosis by FcyRIIb and Phosphatases. In Molecular Mechanisms of Phagocytosis. http://www.eurekah.com/abstract.php?chapid=2221&bookid=1388catid=36
Degrees
| 1983 | B.S., University of Madras, Zoology |
| 1987 | B.Education, Annamalai University, Science Education |
| 1998 | Postdoctoral, Harvard University, Rheumatology/Allergy |
| 1998 | Ph.D., The Ohio State University, Microbiol./Immunol |
| 2000 | Postdoctoral, The Ohio State University, Immunol./Inflammation |
Editorial Activities
Acting Advisory Board
| 2006 | PhD Thesis, University of Melbourne, Australia. |
| 2006 | PhD Thesis, University of Alberta, Edmonton, Alberta, CA. |
Ad Hoc Reviewer
| 2002 | American Journal of Pathology. |
| 2002 | Atherosclerosis, Thrombosis and Vascular Biology. |
| 2002 | Journal of Leukocyte Biology. |
| 2002 | Experimental Hematology. |
Associate Editor
| 2008 - present | Journal of Immunology. |
Journal Editorial Board
| 2011 - present | PLoS ONE. (Journal) |
| 2010 - present | Frontiers in Microbiology. (Journal) |
Journal Journal Reviewer
| 2001 - 2008 | Journal of Immunology. |
Journal Reviewer
| 2002 | Blood. |
| 2002 | Leukemia. |
| 2002 | Cancer Research. |
Honors
| 1996 | ICSABER Award. |
| 1996 | N. Paul Hudson Award. |
| 2000 - 2003 | Fellow, Leukemia and Lymphoma Society Fellow Award. Leukemia and Lymphoma Society. ($105,000.00) |
| 2009 | Invited Lecture at the International Tularemia Conference, Berlin, Germany. International Tularemia Society. Subject: Tularemia |
| 2009 | Chair of Cell Biology Session, International Tularemia Conference, Berlin, Germany. International Tularemia Society. Subject: Tularemia |
| 2009 | Invited lecture. Department of Microbiology, University of Louisville, KY, USA. Subject: Tularemia |
Memberships
| Member. The Ohio State University Comprehensive Cancer Center |
| Member. Dorthy M. Davis Heart and Lung Research Institute |
| Member. American Association of Immunologists |
| Member. American Society for Biochemistry and Molecular Biology |
| Member. American Thoracic Society |
Peer Reviewed Journal Articles
Chacko, G, W; Tridandapani, S; Damen, J, E; Liu, L; Krystal, G; Coggeshall, K M. 1996. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. Journal of immunology (Baltimore, Md. : 1950). Vol. 157, no. 6.
Tridandapani, Susheela; Coggeshall, K. Mark. 1996. Slg-fc-gamma-r Co-crosslinking blocks the Ras signaling pathway and Grb2-shc interaction in B cells. FASEB Journal. Vol. 10, no. 6. : A1065.
Tridandapani, S; Kelley, T; Cooney, D; Pradhan, M; Coggeshall, K M. 1997. Negative signaling in B cells: SHIP Grbs Shc. Immunology today. Vol. 18, no. 9.
Tridandapani, S; Kelley, T; Pradhan, M; Cooney, D; Justement, L, B; Coggeshall, K M. 1997. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Molecular and cellular biology. Vol. 17, no. 8.
Tridandapani, S; Phee, H; Shivakumar, L; Kelley, T, W; Coggeshall, K M. 1998. Role of SHIP in FcgammaRIIb-mediated inhibition of Ras activation in B cells. Molecular immunology. Vol. 35, no. 17.
Jacob, A; Cooney, D; Tridandapani, S; Kelley, T; Coggeshall, K M. 1999. FcgammaRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. The Journal of biological chemistry. Vol. 274, no. 19.
Tridandapani, S; Pradhan, M; LaDine, J, R; Garber, S; Anderson, C, L; Coggeshall, K M. 1999. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells. Journal of immunology (Baltimore, Md. : 1950). Vol. 162, no. 3.
Cooney, D. S.; Tridandapani, S.; Hofmeister, J. K.; Jacob, A.; Coggeshall, K. M. 2000. Proximal signaling events in Fcrgiia mediated phagocytosis. FASEB Journal. Vol. 14, no. 6. : A1233.
Tridandapani S, Smith JL, Lyden TW, Coggeshall KM, CL Anderson. 2000. Linker for activation of T cells (LAT) supports Fcy receptor-mediated signal transduction in myeloid cells. J. Biol. Chem. Vol. 275(27): 20480.
Tridandapani, S; Lyden, T, W; Smith, J, L; Carter, J, E; Coggeshall, K, M; Anderson, C L. 2000. The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells. The Journal of biological chemistry. Vol. 275, no. 27.
Lyden TW, Robinson JM, Tridandapani S, Teillaud J-L, Garber S, Osborn JM, Frey J, CL Anderson. 2001. The IgG receptor expressed in placental endothelial cells is FcyRIIb2. J. Immunol.. Vol. 166: 3882.
Lyden, T, W; Robinson, J, M; Tridandapani, S; Teillaud, J, L; Garber, S, A; Osborne, J, M; Frey, J; Budde, P; Anderson, C L. 2001. The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2. Journal of immunology (Baltimore, Md. : 1950). Vol. 166, no. 6.
Albrecht B, D'Souza CD, Ding W, Tridandapani S, Coggeshall KM, MD Lairmore. 2002. Activationof Nuclear Factor of Activated T Cells (NFAT) by Human T-lymphotropic Virus Type-1 (HTLV-1) accessory protein p12. J. Virol.. Vol. 76(7): 3493-3501.
Albrecht, Bjorn; D'Souza, Celine, D; Ding, Wei; Tridandapani, Susheela; Coggeshall, K Mark; Lairmore, Michael D. 2002. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I). Journal of virology. Vol. 76, no. 7: 3493-501.
Baran, Christopher; Tridandapani, Susheela; Marsh, Clay. 2002. Analysis of the biochemical pathways associated with the macrophage colony-stimulating factor receptor (mcsf-r) and tyrosine-699. FASEB Journal. Vol. 16, no. 5. : A927.
Chi M, Tridandapani S, Zhong W, Coggeshall KM, RF Mortensen. 2002. C-Reactive Protein (CRP) induces signaling through IgG Fc-Receptor (FcyR)IIa on HL-60 granulocytes. J. Immunol.. Vol. 168(3).
Chi, Maoyen; Tridandapani, Susheela; Zhong, Wangjian; Coggeshall, K Mark; Mortensen, Richard F. 2002. C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes. Journal of immunology (Baltimore, Md. : 1950). Vol. 168, no. 3.
Tridandapani S, Siefker K, Teillaud J-L, Carter J, Wewers MD, CL Anderson. 2002. Regulated expression and function of FcyRIIb in human monocyte cells. J. Biol. Chem.. Vol. 277(7): 5082-5089.
Tridandapani S, Wang Y, Marsh CB, CL Anderson. 2002. The SH2 domain containing inositol polyphosphate phosphatase SHIP regulates NFkB-mediated gene transcription by phagocytic Fc gamma Receptors. J. Immunol.. Vol. 169(8): 4370-4378.
Tridandapani, Susheela; Siefker, Kristina; Teillaud, Jean-Luc; Carter, Jo Ellen; Wewers, Mark, D; Anderson, Clark L. 2002. Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells. The Journal of biological chemistry. Vol. 277, no. 7.
Tridandapani, Susheela; Wang, Yijie; Marsh, Clay, B; Anderson, Clark L. 2002. Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-kappa B-mediated gene transcription by phagocytic Fc gamma Rs in human myeloid cells. Journal of immunology (Baltimore, Md. : 1950). Vol. 169, no. 8: 4370-8.
Wang, Yijie; Tridandapani, Susheela; Baran, Chris; Marsh, Clay. 2002. A new paradigm for tyrosine kinase activation by pervanadate in human monocytes. FASEB Journal. Vol. 16, no. 5. : A915.
Wardrop, Richard M.; Tridandapani, Susheela; Marsh, Clay B. 2002. Transforming growth factor beta (tgf-beta) inhibits Fc gamma R-induced monocyte chemoattractant protein-1 (mcp-1). FASEB Journal. Vol. 16, no. 5. : A1080.
Baran, Christopher Phillip; Tridandapani, Susheela; Wang, Yijie; Krystal, Gerald; Marsh, Clay B. 2003. Macrophage colony-stimulating factor recruits Ship1 to the plasma membrane via Grb2 and Lyn and downregulates Akt activity. FASEB Journal. Vol. 17, no. 4-5. : Abstract No. 635.17.
Baran, Christopher, P; Tridandapani, Susheela; Helgason, Cheryl, D; Humphries, R Keith; Krystal, Gerald; Marsh, Clay B. 2003. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. The Journal of biological chemistry. Vol. 278, no. 40: 38628-36.
Ganesan, Latha, P; Fang, Huiqing; Marsh, Clay, B; Tridandapani, Susheela. 2003. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells. The Journal of biological chemistry. Vol. 278, no. 37: 35710-7.
Pengal, Ruma, A; Ganesan, Latha, P; Fang, Huiqing; Marsh, Clay, B; Anderson, Clark, L; Tridandapani, Susheela. 2003. SHIP-2 inositol phosphatase is inducibly expressed in human monocytes and serves to regulate Fcgamma receptor-mediated signaling. The Journal of biological chemistry. Vol. 278, no. 25: 22657-63.
Tridandapani, Susheela; Wardrop, Richard; Baran, Christopher, P; Wang, Yijie; Opalek, Judy, M; Caligiuri, Michael, A; Marsh, Clay B. 2003. TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. Journal of immunology (Baltimore, Md. : 1950). Vol. 170, no. 9: 4572-7.
Wang, Yijie; Baran, Chris; Fang, Huiqing; Tridandapani, Susheela; Marsh, Clay B. 2003. Sh2 domain-containing inositol phosphatase-2 associates with and regulates Mcsf receptor-mediated signaling. FASEB Journal. Vol. 17, no. 4-5. : Abstract No. 852.2.
Ganesan LP; Fang H; Marsh CB; Tridandapani S. 2003. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells. The Journal Of Biological Chemistry. Vol. 278, no. 37. (September 12): 35710.
Baran CP; Tridandapani S; Helgason CD; Humphries RK; Krystal G; Marsh CB. 2003. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. The Journal Of Biological Chemistry. Vol. 278, no. 40. (October 3): 38628.
Baran, Christopher, P; Zeigler, Mandy, M; Tridandapani, Susheela; Marsh, Clay B. 2004. The role of ROS and RNS in regulating life and death of blood monocytes. Current Pharmaceutical Design. Vol. 10, no. 8: 855-866.
Cao, Xianhua; Wei, Guo; Fang, Huiqing; Guo, Jianping; Weinstein, Michael; Marsh, Clay, B; Ostrowski, Michael, C; Tridandapani, Susheela. 2004. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages. Journal of immunology (Baltimore, Md. : 1950). Vol. 172, no. 8: 4851-7.
Fang, Huiqing; Pengal, Ruma, A; Cao, Xianhua; Ganesan, Latha, P; Wewers, Mark, D; Marsh, Clay, B; Tridandapani, Susheela. 2004. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. Journal of immunology (Baltimore, Md. : 1950). Vol. 173, no. 1: 360-6.
Ganesan, Latha, P; Wei, Guo; Pengal, Ruma, A; Moldovan, Leni; Moldovan, Nicanor; Ostrowski, Michael, C; Tridandapani, Susheela. 2004. The serine/threonine kinase Akt Promotes Fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase. The Journal of biological chemistry. Vol. 279, no. 52: 54416-25.
Parihar, Robin; Trotta, Rossana; Tridandapani, Susheela; Roda, Julie M.; Carson, William E., III. 2004. Il-12 potently augments cytokine secretion by Fcr-stimulated Nk cells via enhanced activation of Syk protein tyrosine kinase, Stat4, and the p44/42 Map kinase. Proceedings of the American Association for Cancer Research Annual Meeting. Vol. 45, no. Suppl. S. : 1083.
Wang, Yijie; Keogh, Rosemary, J; Hunter, Melissa, G; Mitchell, Christina, A; Frey, Randall, S; Javaid, Kamran; Malik, Asrar, B; Schurmans, Stephane; Tridandapani, Susheela; Marsh, Clay B. 2004. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. Journal of immunology (Baltimore, Md. : 1950). Vol. 173, no. 11: 6820-30.
Wang, Yijie; Keogh, Rosemary, J; Tridandapani, Susheela; Marsh, Clay B. 2004. Ship2 is Recruited to the Cell Membrane via its Proline-rich Domain upon M-csf Stimulation and Regulates M-csf-induced Signaling. FASEB Journal. Vol. 18, no. 4-5. : Abst. 337.20.
Kutala, Vijay K.; Khan, Mahmood; Varadharaj, Saradhadevi; Ganesan, Prabha L.; Shobha, Jagdish C.; Naidu, Modireddi U.; Parinandi, Narasimham L.; Tridandapani, Susheela; Kuppusamy, Periannan. 2005. C-phycocyanin improves cardiac dysfunction by attenuating oxidative stress and inhibition of p38 Mapk activity in isolated heart subjected to ischemia-reperfusion. Free Radical Biology & Medicine. Vol. 39, no. Suppl. 1. : S35.
Parihar R, Trotta R, Roda JM, Ferketich AK, Tridandapani S, Caligiuri MA, WE Carson. 2005. SHIP1 negatively regulates cytokine production by NK cells stimulated with antibody-coated tumor cells and IL-12. Cancer Research. Vol. 65: 9099-9107.
Parihar, Robin; Trotta, Rossana; Roda, Julie M.; Ferketich, Amy K.; Tridandapani, Susheela; Caligiuri, Nlichael A.; Carson, William E., III. 2005. Src homology 2-containing inositol 5 '-phosphatase 1 negatively regulates Ifn-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Research. Vol. 65, no. 19. : 9099-9107,9080.
Sweeney, Michael, C; Wavreille, Anne-Sophie; Park, Junguk; Butchar, Jonathan, P; Tridandapani, Susheela; Pei, Dehua. 2005. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains. Biochemistry. Vol. 44, no. 45: 14932-47.
Trotta, Rossana; Parihar, Robin; Yu, Jianhua; Becknell, Brian; Allard, Jeffrey 2nd; Wen, Jing; Ding, Wei; Mao, Hsiaoyin; Tridandapani, Susheela; Carson, William, E; Caligiuri, Michael A. 2005. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood. Vol. 105, no. 8: 3011-8.
Wang, Yijie; Zeigler, Mandy M.; Lam, Greg K.; Hunter, Melissa G.; Eubank, Tim D.; Tridandapani, Susheela; Ostrowski, Michael C.; Marsh, Clay B. 2005. Akt activation regulates macrophage survival and differentiation: Role of M-csf and endogenous Ros. Blood. Vol. 106, no. 11, Part 1. : 623A.
Ai J, Maturu A, Johnson W, Wang Y, Marsh CB, S Tridandapani. 2006. SHIP-2 regulates FcyR-mediated phagocytosis in murine macrophages independently of SHIP-1. Blood. Vol. 107(2): 813-20.
Ai, Jing; Maturu, Amita; Johnson, Wesley; Wang, Yijie; Marsh, Clay, B; Tridandapani, Susheela. 2006. The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1. Blood. Vol. 107, no. 2: 813-20.
Butchar, Jonathan, P; Parsa, Kishore V, L; Marsh, Clay, B; Tridandapani, Susheela. 2006. Negative regulators of Toll-like receptor 4-mediated macrophage inflammatory response. Current Pharmaceutical Design. Vol. 12, no. 32: 4143-4153.
Ganesan, Latha, P; Joshi, Trupti; Fang, Huiqing; Kutala, Vijay Kumar; Roda, Julie; Trotta, Rossana; Lehman, Amy; Kuppusamy, Periannan; Byrd, John, C; Carson, William, E; Caligiuri, Michael, A; Tridandapani, Susheela. 2006. FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood. Vol. 108, no. 2: 718-25.
Imhof, Diana; Wavreille, Anne-Sophie; May, Andreas; Zacharias, Martin; Tridandapani, Susheela; Pei, Dehua. 2006. Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position. The Journal of biological chemistry. Vol. 281, no. 29: 20271-82.
Joshi T, Butchar JP, S Tridandipani. 2006. Fc gamma receptor-mediated signaling in phagocytes. Int. J. of Hematol. Vol. 84, no. 3.
Joshi, Trupti; Ganesan, Latha, P; Cao, Xianhua; Tridandapani, Susheela. 2006. Molecular analysis of expression and function of hFcgammaRIIbl and b2 isoforms in myeloid cells. Molecular immunology. Vol. 43, no. 7: 839-50.
Khan, Mahmood; Varadharaj, Saradhadevi; Ganesan, Latha, P; Shobha, Jagdish, C; Naidu, Madireddi, U; Parinandi, Narasimham, L; Tridandapani, Susheela; Kutala, Vijay Kumar; Kuppusamy, Periannan. 2006. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. American journal of physiology. Heart and circulatory physiology. Vol. 290, no. 5: H2136-45.
Kutala, Vijay Kumar; Khan, Mahmood; Mandal, Rajarsi; Ganesan, Latha, P; Tridandapani, Susheela; Kalai, Tamas; Hideg, Kalman; Kuppusamy, Periannan. 2006. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. The Journal of pharmacology and experimental therapeutics. Vol. 317, no. 3: 921-8.
Mone, A, P; Cheney, C; Banks, A, L; Tridandapani, S; Mehter, N; Guster, S; Lin, T; Eisenbeis, C, F; Young, D, C; Byrd, J C. 2006. Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. Vol. 20, no. 2: 272-9.
Parsa, Kishore V, L; Ganesan, Latha, P; Rajaram, Murugesan V, S; Gavrilin, Mikhail, A; Balagopal, Ashwin; Mohapatra, Nrusingh, P; Wewers, Mark, D; Schlesinger, Larry, S; Gunn, John, S; Tridandapani, Susheela. 2006. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS pathogens. Vol. 2, no. 7: e71.
Pengal, Ruma, A; Ganesan, Latha, P; Wei, Guo; Fang, Huiqing; Ostrowski, Michael, C; Tridandapani, Susheela. 2006. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Molecular immunology. Vol. 43, no. 10: 1557-64.
Rajaram, Murugesan V, S; Ganesan, Latha, P; Parsa, Kishore V, L; Butchar, Jonathan, P; Gunn, John, S; Tridandapani, Susheela. 2006. Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice. Journal of immunology (Baltimore, Md. : 1950). Vol. 177, no. 9: 6317-24.
Roda, Julie M.; Parihar, Robin; Tridandapani, Susheela; Carson, William E., III. 2006. Il-21 enhances natural killer cell activation in response to antibody-coated tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting. Vol. 47. : 150-151.
Roda, Julie, M; Parihar, Robin; Lehman, Amy; Mani, Aruna; Tridandapani, Susheela; Carson, William E 3rd. 2006. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. Journal of immunology (Baltimore, Md. : 1950). Vol. 177, no. 1: 120-9.
Roda, Julie, M; Parihar, Robin; Magro, Cynthia; Nuovo, Gerard, J; Tridandapani, Susheela; Carson, William E 3rd. 2006. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer research. Vol. 66, no. 1: 517-26.
Sardjono, Caroline, T; Harbour, Stacey, N; Yip, Jana, C; Paddock, Cathy; Tridandapani, Susheela; Newman, Peter, J; Jackson, Denise E. 2006. Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection. Thrombosis and haemostasis. Vol. 96, no. 6: 756-66.
Zhao, Xiaobin B.; Trupti, Joshi; Lapalombella, Rosa; Cheney, Carolyn; Gowda, Aruna; Hayden-Ledbetter, Martha S.; Baum, Peter R.; Lin, Thomas S.; Jarjoura, David; Lehman, Amy; Lee, Robert J.; Caligiuri, Michael A.; Tridandapani, Susheela; Muthusamy, Natarajan; Byrd, John C. 2006. Nk cells contribute significantly to the innate immune effector role of Cd37-specific Smip in Cll and Nhl. Blood. Vol. 108, no. 11, Part 1. : 44A.
Butchar, Jonathan, P; Rajaram, Murugesan V, S; Ganesan, Latha, P; Parsa, Kishore V, L; Clay, Corey, D; Schlesinger, Larry, S; Tridandapani, Susheela. 2007. Francisella tularensis induces IL-23 production in human monocytes. Journal of immunology (Baltimore, Md. : 1950). Vol. 178, no. 7.
Roda, Julie, M; Joshi, Trupti; Butchar, Jonathan, P; McAlees, Jaclyn, W; Lehman, Amy; Tridandapani, Susheela; Carson, William E 3rd. 2007. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clinical cancer research : an official journal of the American Association for Cancer Research. Vol. 13, no. 21.
Wang, Yijie; Zeigler, Mandy, M; Lam, Gregory, K; Hunter, Melissa, G; Eubank, Tim, D; Khramtsov, Valery, V; Tridandapani, Susheela; Sen, Chandan, K; Marsh, Clay B. 2007. The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. American journal of respiratory cell and molecular biology. Vol. 36, no. 1: 68-77.
Weir, Nathan, M; Selvendiran, Karuppaiyah; Kutala, Vijay Kumar; Tong, Liyue; Vishwanath, Shilpa; Rajaram, Murugesan; Tridandapani, Susheela; Anant, Shrikant; Kuppusamy, Periannan. 2007. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer biology & therapy. Vol. 6, no. 2.
Zhao, Xiaobin; Lapalombella, Rosa; Joshi, Trupti; Cheney, Carolyn; Gowda, Aruna; Hayden-Ledbetter, Martha, S; Baum, Peter, R; Lin, Thomas, S; Jarjoura, David; Lehman, Amy; Kussewitt, Donna; Lee, Robert, J; Caligiuri, Michael, A; Tridandapani, Susheela; Muthusamy, Natarajan; Byrd, John C. 2007. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood. Vol. 110, no. 7.
Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, Marsh CB, Schlesinger LS, Tridandapani S. 2008. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS ONE. Vol. 3, no. 8: e2924.
Butchar, J.P., Parsa, K.V.L., Marsh, C.B. and S. Tridandapani. 2008. IFNgamma enhances IL-23 production during Francisella infection of human monocytes. FEBS Letters. Vol. 582, no. 7: 1044-1088. (IF: 3.263)
Cremer TJ, Tridandapani S. 2008. Effective host response to Francisella requires functional mast cells. Future Microbiology. Vol. 3: 503-6. (IF: 0.645)
Cremer, Amer, Tridandapani, Butchar. 2008. Francisella tularensis regulates autophagy-related pathways. Autophagy. Vol. 1, no. 5: 125-128.
Crouser, Shao, Julian, Macre, Shadel, Tridandapani, Huang and Wewers. Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit. Care. Med.. (In press)
Henning, Lisa, N; Azad, Abul, K; Parsa, Kishore V, L; Crowther, Joy, E; Tridandapani, Susheela; Schlesinger, Larry S. 2008. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. Journal of immunology (Baltimore, Md. : 1950). Vol. 180, no. 12. (IF: 6.068)
Joshi, Ganesan, Cheney, Ostrowski, Muthusamy, Byrd and Tridandapani. 2008. The PtdIns3-kinase/Akt pathway regulates macrophage-mediated ADCC against B cell lymphoma. PLoS ONE. Vol. 1, no. 4: e4208.
Kamen LA, Levinsohn J, Cadwallader A, Tridandapani S, Swanson JA. 2008. SHIP-1 Increases Early Oxidative Burst and Regulates Phagosome Maturation in Macrophages. J. Immunol. Vol. 180, no. 11: 7497-505. (IF: 6.068)
Lapalombella, Gowda, Joshi, Mehter, Cheney, Lehman, Chen, Johnson, Caligiuri, Tridandapani, Muthusamy and Byrd. The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in CLL. Brit. J. Hematol.. (In press)
Lapalombella, Yu, Triantafillou, Liu, Butchar, Lozanski, Ramanunni, Smith, Blum, Andritsos, Wang, Lehman, Chen, Johnson, Marcucci, Lee, Lee, Tridandapani, Muthusamy and Byrd. 2008. Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of Rituximab on primary CLL cells. Blood. Vol. 112, no. 13: 5180-5189.
Parsa KVL, Butchar JP, Rajaram MVS, Gunn JS, Schlesinger LS, Tridandapani S. 2008. Francisella gains a survival advantage within mononuclear phagocytes by suppressing host IFN? response. Mol. Immunol.. Vol. 45, no. 12: 3428-37. (IF: 3.742)
Parsa, K.V.L., Butchar, J.P., Rajaram, M.V.S. and S. Tridandapani. 2008. The tyrosine kinase Syk promotes the uptake of Francisella infection of human monocytes. Molecular Immunology. Vol. 45, no. 10: 3012-3021. (IF: 3.742)
Kondadasula, S., Roda, J., Parihar, R., Yu, J., Caligiuri, M.A., Tridandapani, S., Burry, R., and W.E. Carson. 2008. Co-localization of the IL-12 receptor and FcyRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-y. Blood. Vol. 111, no. 8. (January 4): 4173-4183. Epub ahead of print. (IF: 10.896)
Gowda, Al, Roda, J., Ramanunni, Al, Joshi, Tl, Schmidt, S., Jarjoura, D., Kindsvogel, W., Cheney, C., Caligiuri, M.A., Tridandapani, S., Carson, W.E., Muthusamy, N., and J. Byrd. 2008. IL-21 Mediates Apoptosis Through Up-Regulation of the BH3 Family Member BIM and Enhances both Direct and Antibody Dependent Cellular Cytotoxicity in Primary Chronic Lymphocytic Cells. Blood. Vol. 111, no. 9. (January 11): 4723-4730. (IF: 10.896)
Henning LN; Azad AK; Parsa KV; Crowther JE; Tridandapani S; Schlesinger LS. 2008. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. Journal Of Immunology (Baltimore, Md.: 1950). Vol. 180, no. 12 (June 15): 7847.
Parsa KV; Butchar JP; Rajaram MV; Cremer TJ; Gunn JS; Schlesinger LS; Tridandapani S. 2008. Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Molecular Immunology. Vol. 45, no. 12 (July 1): 3428.
Lapalombella R; Yu B; Triantafillou G; Liu Q; Butchar JP; Lozanski G; Ramanunni A; Smith LL; Blum W; Andritsos L; Wang DS; Lehman A; Chen CS; Johnson AJ; Marcucci G; Lee RJ; Lee LJ; Tridandapani S; Muthusamy N; Byrd JC. 2008. Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood. Vol. 112, no. 13 (December 15): 5180.
Awan, Farrukh; Lapalombella, Rosa; Trotta, Rossana; Butchar, Jonathan P.; Yu, Bo; Benson, Don; Cheney, Carolyn; Mo, Xiaokui; Lehman, Amy; Jones, Jeffrey Alan; Flynn, Joseph M.; Jarjoura, David; Baiocchi, Robert A.; Desjarlais, John; Tridandapani, Susheela; Caligiuri, Michael A.; Muthusamy, Natarajan; Byrd, John C. 2009. Cd19 Targeting of Lymphoid Malignancies by Novel Fc-domain Engineered Monoclonal Antibody. Blood. Vol. 114, no. 22. : 1435.
Butchar, Jonathan P.; Mehta, Payal; Justiniano, Steven E.; Guenterberg, Kristan D.; Kanneganti, Thirumala-Devi; Amer, Amal; Muthusamy, Natarajan; Jarjoura, David; Marsh, Clay B.; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela. 2009. Tlr7/8 Differentially Regulates Fc gamma Receptor Expression and Function. Blood. Vol. 114, no. 22. : 1391-1392.
Lapalombella, R.; Yu, B.; Triantafillou, G.; Liu, Q.; Butchar, J. P.; Lozanski, G.; Ramanunni, A.; Smith, L. L.; Blum, W.; Andritsos, L.; Wang, D. S.; Lehman, A.; Chen, C. S.; Johnson, A. J.; Marcucci, G.; Lee, R. J.; Lee, L. J.; Tridandapani, S.; Muthusamy, N.; Byrd, J. C. 2009. Lenalidomide down-regulates the Cd20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells (vol 112, pg 5180, 2008). Blood. Vol. 114, no. 16. : 3506.
Cremer TJ; Amer A; Tridandapani S; Butchar JP. 2009. Francisella tularensis regulates autophagy-related host cell signaling pathways. Autophagy. Vol. 5, no. 1 (January 1): 125.
Cremer TJ; Ravneberg DH; Clay CD; Piper-Hunter MG; Marsh CB; Elton TS; Gunn JS; Amer A; Kanneganti TD; Schlesinger LS; Butchar JP; Tridandapani S. 2009. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. Plos One. Vol. 4, no. 12 (January 1): e8508.
Joshi T; Ganesan LP; Cheney C; Ostrowski MC; Muthusamy N; Byrd JC; Tridandapani S. 2009. The PtdIns 3-kinase/Akt pathway regulates macrophage-mediated ADCC against B cell lymphoma. Plos One. Vol. 4, no. 1 (January 1): e4208.
Rajaram MV; Butchar JP; Parsa KV; Cremer TJ; Amer A; Schlesinger LS; Tridandapani S. 2009. Akt and SHIP modulate Francisella escape from the phagosome and induction of the Fas-mediated death pathway. Plos One. Vol. 4, no. 11 (January 1): e7919.
Lapalombella R; Gowda A; Joshi T; Mehter N; Cheney C; Lehman A; Chen CS; Johnson AJ; Caligiuri MA; Tridandapani S; Muthusamy N; Byrd JC. 2009. The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. British Journal Of Haematology. Vol. 144, no. 6 (March 1): 848.
Akhter A; Gavrilin MA; Frantz L; Washington S; Ditty C; Limoli D; Day C; Sarkar A; Newland C; Butchar J; Marsh CB; Wewers MD; Tridandapani S; Kanneganti TD; Amer AO. 2009. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. Plos Pathogens. Vol. 5, no. 4 (April 1): e1000361.
Crouser ED; Shao G; Julian MW; Macre JE; Shadel GS; Tridandapani S; Huang Q; Wewers MD. 2009. Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Critical Care Medicine. Vol. 37, no. 6 (June 1): 2000.
Awan FT; Lapalombella R; Trotta R; Butchar JP; Yu B; Benson DM Jr; Roda JM; Cheney C; Mo X; Lehman A; Jones J; Flynn J; Jarjoura D; Desjarlais JR; Tridandapani S; Caligiuri MA; Muthusamy N; Byrd JC. 2010. CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood. Vol. 115, no. 6. : 1204.
Butchar JP; Mehta P; Justiniano SE; Guenterberg KD; Kondadasula SV; Mo X; Chemudupati M; Kanneganti TD; Amer A; Muthusamy N; Jarjoura D; Marsh CB; Carson WE 3rd; Byrd JC; Tridandapani S. 2010. Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy. Clinical Cancer Research: An Official Journal Of The American Association For Cancer Research. Vol. 16, no. 7. : 2065.
Butchar, Jonathan P.; Mehta, Payal; Justiniano, Steven E.; Guenterberg, Kristan D.; Kondadasula, Sri-Vidya; Mo, Xiaokui; Chemudupati, Mahesh; Kanneganti, Thirumala-Devi; Amer, Amal; Muthusamy, Natarajan; Jarjoura, David; Marsh, Clay B.; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela. 2010. Reciprocal Regulation of Activating and Inhibitory Fc gamma Receptors by Tlr7/8 Activation: Implications for Tumor Immunotherapy. Clinical Cancer Research. Vol. 16, no. 7. : 2065-2075.
Cremer TJ, Butchar JP, Tridandapani S. 2011. Francisella Subverts Innate Immune Signaling: Focus On PI3K/Akt. Frontiers in Microbiology.
Cremer TJ, Shah P, Cormet-Boyaka E, Valvano MA, Butchar JP and S Tridandapani. 2011. Akt-mediated pro-inflammatory response of mononuclear phagocytes infected with Burkholderia cenocepacia occurs by a novel GSK3β-dependent, IKK-independent mechanism. Journal of Immunology. (IF: 5.646)
Mehta P, Wavreille A, Justiniano SE, Marsh RL ,Yu J, Burry R, Jarjoura D, Eubank T, Caligiuri MA, Butchar JP, and S Tridandapani. 2011. LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis. PLoS ONE. (IF: 4.35)
Yu J, Mitsui T, Wei M, Mao H, Butchar JP, Shah MV, Zhang J, Mishra A, Alvarez-Breckenridge C, Liu X, Liu S, Yokohama A, Trotta R, Marcucci G, Benson DM Jr, Loughran TP Jr, Tridandapani S, Caligiuri MA. 2011. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest.. (IF: 15.387)
Positions
| 1986 - 1988 | Instructor, Alpha Matriculation School - India. |
| 1990 - 1993 | Biology Instructor, St. Margaret's School - Brunei Darussalam. |
| 1997 - 1998 | Graduate Research Associate , The Ohio State University, Microbiology Admin . Columbus, OH, United States. |
| 1998 | Post-doctoral Fellow, Harvard Medical School, Rheumatology/Allergy. Boston, MA, United States. |
| 1998 - 2000 | Post-doctoral Fellow, The Ohio State University, Immunology. Columbus, OH, United States. |
| 1998 - 2000 | Post Doctoral Researcher , The Ohio State University, Internal Medicine . Columbus, OH, United States. |
| 2000 - 2002 | Research Scientist, The Ohio State University, Department of Internal Medicine. Columbus, OH, United States. |
| 2002 - 2002 | Research Scientist , The Ohio State University, Pulm,Allergy,Crit Care & Sleep . Columbus, OH, United States. |
| 2002 - 2006 | Assistant Professor, The Ohio State University, Department of Internal Medicine, MCDB, IBGP, OSBP, CBIP and Biophysics Program. Columbus, OH, United States. |
| 2006 - 2009 | Associate Professor, The Ohio State University, Department of Internal Medicine / Pulmonary Division. Columbus, OH, United States. |
| 2006 - 2009 | Member, Education Committee, The Ohio State University, Medicine, Davis Heart and Lung Research Institute. Columbus, OH, United States. |
| 2006 - present | Director, PhD Postdoc/Predoc Education Program, The Ohio State University, Medicine, Pulmonary Division. Columbus, OH, United States. |
| 2007 - present | Director, Academic Affairs, The Ohio State University, Medicine, Pulmonary. Columbus, OH, United States. |
| 2007 - present | Associate Director, Pulmonary T32 Program, Molecular Mechanisms of Lung Inflammation, The Ohio State University, Medicine, Pulmonary. Columbus, OH, United States. |
| 2008 - present | Member, Signature Program Translational Curriculum Development Committee, The Ohio State University, Medicine. Columbus, OH, United States. |
| 2008 - present | Member, School of Biomedical Sciences Executive Committee, The Ohio State University, Medicine. Columbus, OH, United States. |
| 2009 - present | Professor, The Ohio State University College of Medicine, Medicine, Internal Medicine. Columbus, OH, United States. |
| 2009 - present | Co-Director of Research, The Ohio State University College of Medicine, Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine. Columbus, OH, United States. |
| 2009 - present | Member, Admissions Committee, The Ohio State University College of Medicine, Medicine, College of medicine. Columbus, OH, United States. |
Presentations
Invited Presentations
Local
Susheela Tridandapani, Presenter. 2003. Differential Regulation of Innate Immune Responses by Inositol Phosphatases: FcR versus TLR4. to Davis Heart and Lung Research Institute. The Ohio State University.
Susheela Tridandapani, Presenter. 2003. Homeostatic Control of FcR-mediated Macrophage Function: Identification and Characterization of a Novel Regulatory Identification and Characterization of a Novel Regulatory Influence by SHIP-2. to Integrated Biomedical Graduate Program. The Ohio State University.
Susheela Tridandapani, Presenter. 2003. Regulation of FcRIIb Expression and Function by TH2 Cytokines. to Department of Molecular Virology, Immunology and Medicial Genetics. The Ohio State University.
Susheela Tridandapani, Presenter. 2003. Signal Transduction During Macrophage Innate Immune responses. to Molecular, Cellular and Developmental Biology Program. The Ohio State University.
Susheela Tridandapani, Presenter. 2003. The Novel Inositol Phosphatase SHIP-2 Regulates FcR-mediated Signal Transduction in Macrophages. to Department of Pathology. The Ohio state University.
Susheela Tridandapani, Presenter. 2004. Molecular Mechanisms Involved in the Regulation of Macrophage Response to Immune-Complexes. to Center for Microbial Interface Biology. The Ohio State University.
Susheela Tridandapani, Presenter. 2005. Novel Role of Akt in FcR-Mediated Macrophage Function. to Department of Pathology. The Ohio State University.
Susheela Tridandapani, Presenter. 2006. Homeostatic Control of Macrophage Fc Receptor-Mediated Phagocytosis. Presented at Karl P. Klassen Lecture and Research Day. The Ohio State University. Columbus, OH, USA.
Susheela Tridandapani, Presenter. 2006. Molecular Mechanisms Involved in the Regulation of Macrophage Response to Immune-Complexes. to Chemistry and Biology Interphase program. The Ohio State University.
Susheela Tridandapani, Presenter. 2007. Mechanisms of Macrophage Response to Antibody-Coated Target Cells. to Department of Pathology. The Ohio State University.
Susheela Tridandapani, Presenter. 2008. Molecular Regulation of Macrophage Fcgamma receptor Function. to Department of Pathology. The Ohio State University.
State
Susheela Tridandapani, Presenter. 2000. Modulation of Fc gamma receptor expression: A key to enhancing antibody therapy for cancer. to Board of Trustees, Leukemia and Lymphoma Society Ohio Chapter. Columbus, OH, USA.
Regional
Susheela Tridandapani, Presenter. 1999. Fc gamma Receptors: Multiplicity in Structure and Function. to Department of Microbiology. University of Michigan. Ann Arbor, MI, USA.
National
Susheela Tridandapani, Presenter. 1999. Fc gamma Receptors: Multiplicity in Structure and Function. to Department of Pathology. University of Texas Southwestern Medical Center. Dallas, TX, USA.
Susheela Tridandapani, Presenter. 2003. Homeostatic Control of Fcganna receptor-mediated macrophage Function: Identification and Characterization of a Novel Regulatory Influence by SHIP-2. Presented at Regional Cancer center Consortium for Biological Treatment of Cancer. Columbus, OH, USA.
Susheela Tridandapani, Presenter. 2006. Homeostatic Control of macrophage inflammatory response to IgG immune complexes. to Department of Biomedical Sciences. Cornell University. Ithaca, NY, USA.
International
Susheela Tridandapani, Presenter. 2006. Homeostatic control of Fc receptor function: Identification and Characterization of a novel regulatory influence by SHIP-2. University of Alberta. Edmonton, Alberta, Canada.
Professional Activities
Education
| 2003 | High School Student - Katie Hua. Research Advisor. The Ohio State University. Columbus, OH. |
| 2006 - present | Karen Wood - Young Faculty. Research Advisor. The Ohio State University. Columbus, OH. |
| 2008 - present | Estelle Cormet-Boyaka - Young Faculty. Mentor. The Ohio State University. Columbus, OH. |
| 2008 | Valery Khramstov - Young Faculty. Mentor. The Ohio State University. Columbus, OH. |
| 2008 - 2009 | Jeanette Marketon - Young Faculty. Mentor. The Ohio State University. Columbus, OH. |
| 2008 - 2009 | Amal Amer - Young Faculty. Mentor. The Ohio State University. Columbus, OH. |
Other
| 2010 - present | Editorial Board. Editorial Activity. Frontiers in Cellular and Microbial Immunology. |
Research
| 2003 | NIH / NCI, Review group NCI-C RTRB. Grant Reviewer. Key achievements: Published in Review Group, NCI-RTRB |
| 2003 | NIH / NHLBI, HLBP Study Section. Grant Reviewer. |
| 2004 | NIAID/IMS Special Emphasis Panel. Grant Reviewer. |
| 2004 | NIAID, IMS Special Emphasis Panel. Grant Reviewer. |
| 2007 | NIAID ZA11 LR-1 J1 Scientific Review Group. Grant Reviewer. |
| 2007 | NIAID, ZAI1-BLG-M-J1 Scientific Review Group. Grant Reviewer. |
| 2008 - present | NIAID, ZA11-JSR-1-S2. Grant Reviewer. |
| 2008 - present | NIAID, Metzger P01 A1. Grant Reviewer. |
| 2008 - present | KUMC R1. Grant Reviewer. |
| 2008 | NIAID, ZA11-BLG-M-J1. Grant Reviewer. |
| 2010 | P01 Grant Review, Secial Emphasis Panel. Grant Reviewer. NIH. |
| 2011 - present | Lytmos Foundation Grant Reviewer. Grant Reviewer. Lytmos Foundation. |
| 2011 - present | P01 Reviewer. Study Section. NIAID. |
| 2011 - present | NIH Director's Innovator Award Reviewer. Grant Reviewer. NIAID. |
Reviews
2008. Review of Effective host response to Francisella tularensis requires functional mast cells., by Cremer TJ; Tridandapani S. (October 01): 503. (Published)
Undergrad., Grad. and Prof. Courses Taught
Autumn 2002. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Winter 2003. The Ohio State University College of Medicine, BIOPHYSICS. Research in Biophysics 999. 14 credit hours
Winter 2003. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 4 credit hours
Spring 2003. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 9 credit hours
Spring 2003. The Ohio State University, Immunology Seminars Pathology 850. 1 credit hours
Summer 2003. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 7 credit hours
Summer 2003. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 10 credit hours
Autumn 2003. The Ohio State University, Advanced Seminars MVIMG 850. 1 credit hours
Autumn 2003. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Autumn 2003. The Ohio State University, BIOPHYSICS. Research in Biophysics 999. 14 credit hours
Autumn 2003. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 4 credit hours
Winter 2004. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 8 credit hours
Winter 2004. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 5 credit hours
Winter 2004. The Ohio State University College of Medicine, BIOPHYSICS. Research in Biophysics 999. 18 credit hours
Spring 2004. The Ohio State University College of Medicine, BIOPHYSICS. Research in Biophysics 999. 11 credit hours
Spring 2004. The Ohio State University, Student Research Seminars MCDB 800/890. 1 credit hours
Spring 2004. The Ohio State University, Host-Pathogen Seminar Series IBGP 795. 1 credit hours
Spring 2004. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 6 credit hours
Summer 2004. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 7 credit hours
Autumn 2004. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 7 credit hours
Autumn 2004. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 8 credit hours
Autumn 2004. The Ohio State University, Graduate Student Mentoring Biochem 760. 1 credit hours
Autumn 2004. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Winter 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Individual Studies 793. 3 credit hours
Winter 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 8 credit hours
Winter 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 10 credit hours
Winter 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 12 credit hours
Spring 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 10 credit hours
Spring 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 12 credit hours
Spring 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 15 credit hours
Spring 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 10 credit hours
Spring 2005. The Ohio State University, Immunology Seminars Pathology 850. 1 credit hours
Summer 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 12 credit hours
Summer 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 15 credit hours
Summer 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 15 credit hours
Autumn 2005. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 15 credit hours
Autumn 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 15 credit hours
Autumn 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 9 credit hours
Autumn 2005. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 10 credit hours
Autumn 2005. The Ohio State University, Graduate Student Mentoring Biochem 760.
Autumn 2005. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Winter 2006. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 6 credit hours
Winter 2006. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 9 credit hours
Winter 2006. The Ohio State University, INTERNAL MEDICINE. Allergy 850.01. 3 credit hours
Winter 2006. The Ohio State University, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Research in Molecular, Cellular, and Developmental Biology 999. 15 credit hours
Winter 2006. The Ohio State University, INTERNAL MEDICINE. Allergy 850.01. 1 credit hours
Spring 2006. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 5 credit hours
Spring 2006. The Ohio State University, INTERNAL MEDICINE. Allergy 850.01. 1 credit hours
Spring 2006. The Ohio State University, BIOCHEMISTRY PROGRAM. Research in Biochemistry 999.01. 9 credit hours
Summer 2006. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 12 credit hours
Summer 2006. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 9 credit hours
Autumn 2006. The Ohio State University, INTERNAL MEDICINE. Allergy 850.01. 1 credit hours
Autumn 2006. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 9 credit hours
Autumn 2006. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 10 credit hours
Autumn 2006. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Autumn 2006. The Ohio State University, Introduction to topics in Cell Biophysics Biophys 702. 3 credit hours
Winter 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 7 credit hours
Winter 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Allergy 850.01. 1 credit hours
Winter 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 9 credit hours
Spring 2007. The Ohio State University College of Medicine, BIOCHEMISTRY PROGRAM. Individual Studies 793. 4 credit hours
Spring 2007. The Ohio State University College of Medicine, MOLECULAR,CELLULAR,AND DEVELOPMENTAL BIOLOGY. Individual Studies 693. 2 credit hours
Spring 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 9 credit hours
Spring 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 10 credit hours
Spring 2007. The Ohio State University, Immunology Seminars Pathology 850. 1 credit hours
Summer 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 7 credit hours
Summer 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 12 credit hours
Summer 2007. The Ohio State University College of Medicine, INTERNAL MEDICINE. Research in Medicine 999. 12 credit hours
Autumn 2007. The Ohio State University, Molecular Immunology MVIMG 701. 5 credit hours
Autumn 2007. The Ohio State University, Introduction to Cell Biophysics Biophys 702. 3 credit hours
Autumn 2007. The Ohio State University, INTERNAL MEDICINE. Allergy 850.01. 1 credit hours
Autumn 2007. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 7 credit hours
Autumn 2007. The Ohio State University, INTERNAL MEDICINE. Research in Medicine 999. 9 credit hours
Winter 2008. The Ohio State University, INTERNAL MEDICINE. SEMINAR ALLERGY 850.01. 3 credit hours
Winter 2008. The Ohio State University, INTEGRATED BIOMEDICAL SCIENCE. INDIVIDUAL STUDIES 793. 12 credit hours
Winter 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 2 credit hours
Winter 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 6 credit hours
Winter 2008. The Ohio State University, INTERNAL MEDICINE. SEMINAR ALLERGY 850.01. 1 credit hours
Winter 2008. The Ohio State University, Internal Medicine. Signal Transduction in the Immune System Int Med 850.01. 1 credit hours
Spring 2008. The Ohio State University, Internal Medicine. Signal Transduction in the Immune System Int Med 850.01. 1 credit hours
Spring 2008. The Ohio State University, INTEGRATED BIOMEDICAL SCIENCE. DISSERTATION RES 999. 14 credit hours
Spring 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 9 credit hours
Spring 2008. The Ohio State University, INTERNAL MEDICINE. SEMINAR ALLERGY 850.01. 1 credit hours
Spring 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 3 credit hours
Summer 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 7 credit hours
Summer 2008. The Ohio State University, INTEGRATED BIOMEDICAL SCIENCE. DISSERTATION RES 999. 12 credit hours
Summer 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 9 credit hours
Autumn 2008. The Ohio State University, INTEGRATED BIOMEDICAL SCIENCE. DISSERTATION RES 999. 15 credit hours
Autumn 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 10 credit hours
Autumn 2008. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 12 credit hours
Autumn 2008. The Ohio State University, Internal Medicine. Signal Transduction in the Immune System Int Med 850.01. 1 credit hours
Autumn 2008. The Ohio State University, MVIMG. Molecular Immunology MVIMG 701. 5 credit hours
Winter 2009. The Ohio State University, INTEGRATED BIOMEDICAL SCIENCE. DISSERTATION RES 999. 12 credit hours
Winter 2009. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 15 credit hours
Winter 2009. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 7 credit hours
Winter 2009. The Ohio State University, INTERNAL MEDICINE. SEMINAR ALLERGY 850.01. 1 credit hours
Spring 2009. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 14 credit hours
Spring 2009. The Ohio State University, INTERNAL MEDICINE. RESEARCH 999. 7 credit hours
Spring 2009. The Ohio State University, INTERNAL MEDICINE. SEMINAR ALLERGY 850.01. 1 credit hours
Summer 2009. The Ohio State University, Internal Medicine. Research 999. 25 credit hours
Summer 2009. The Ohio State University, Integrated Biomedical Science. Dissertation Res 999. 18 credit hours
Autumn 2009. The Ohio State University, Internal Medicine. Research 999. 25 credit hours
Autumn 2009. The Ohio State University, Ohio State Biochemistry Prg. Individual Studies 793. 5 credit hours
Winter 2010. The Ohio State University, Internal Medicine. Research 999. 25 credit hours
Spring 2010. The Ohio State University, Internal Medicine. Research 999. 25 credit hours
Autumn 2010. The Ohio State University, Integrated Biomedical Science. SPTS-Immunology 880.01. 3 credit hours.
Autumn 2010. The Ohio State University, Internal Medicine. Signal Transduction in the Immune System 850.01. 1 credit hours
Winter 2011. Allied Medical Profession COLMBUS, Biomedical Science. Undergrad Research 699 . 5 credit hours
Winter 2011. The College of Medicine COLMBUS, Internal Medicine. Research 999 . 25 credit hours
Winter 2011. The College of Medicine COLMBUS, Integrated Biomedical Science. Individual Studies 793 . 15 credit hours
Spring 2011. Allied Medical Profession COLMBUS, Biomedical Science. Undergrad Research 699 . 5 credit hours
Spring 2011. The College of Medicine COLMBUS, Internal Medicine. Research 999 . 25 credit hours
Summer 2011. The College of Medicine COLMBUS, Internal Medicine. Research 999 . 25 credit hours
Summer 2011. The College of Medicine COLMBUS, Integrated Biomedical Science. Dissertation Res 999 . 18 credit hours
Autumn 2011. The College of Medicine COLMBUS, Integrated Biomedical Science. SPTS-Immunology 880.01. 3 credit hours
Autumn 2011. The College of Medicine COLMBUS, Internal Medicine. Seminar Allergy 850.01. 3 credit hours
Winter 2012. Allied Medical Profession COLMBUS, Biomedical Science. Bms Research Exp 2 720.02. 5 credit hours
Winter 2012. Allied Medical Profession COLMBUS, Biomedical Science. Undergrad Research 699 . 5 credit hours
Winter 2012. The College of Medicine COLMBUS, Integrated Biomedical Science. Dissertation Res 999 . 18 credit hours
